You just read:

Phoenix Tissue Repair Receives FDA Fast Track Designation for PTR-01 for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) and Provides Updates on the Phase 1/2 Clinical Study

News provided by

Phoenix Tissue Repair, Inc.

Apr 30, 2019, 08:00 ET